HETERO LABS LTD III FDA Approval ANDA 206419

ANDA 206419

HETERO LABS LTD III

FDA Drug Application

Application #206419

Application Sponsors

ANDA 206419HETERO LABS LTD III

Marketing Status

Prescription001
Prescription002

Application Products

001CAPSULE, EXTENDED RELEASE;ORAL2MG0TOLTERODINE TARTRATETOLTERODINE TARTRATE
002CAPSULE, EXTENDED RELEASE;ORAL4MG0TOLTERODINE TARTRATETOLTERODINE TARTRATE

FDA Submissions

UNKNOWN; ORIG1AP2017-12-12STANDARD

Submissions Property Types

ORIG1Null15

TE Codes

001PrescriptionAB
002PrescriptionAB

CDER Filings

HETERO LABS LTD III
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 206419
            [companyName] => HETERO LABS LTD III
            [docInserts] => ["",""]
            [products] => [{"drugName":"TOLTERODINE TARTRATE","activeIngredients":"TOLTERODINE TARTRATE","strength":"2MG","dosageForm":"CAPSULE, EXTENDED RELEASE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"TOLTERODINE TARTRATE","activeIngredients":"TOLTERODINE TARTRATE","strength":"4MG","dosageForm":"CAPSULE, EXTENDED RELEASE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"12\/12\/2017","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2017-12-12
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.